Press Release | Wed Jun 12, 2013 1:11pm EDT

AstraZeneca and Bristol-Myers Squibb Statement on Proposal by the American Diabetes Association for Independent Review of Incretin-Based Therapies

* Reuters is not responsible for the content in this press release.